top of page

ASGCT 2026: Arbor Biotechnologies presented in vivo data today showing that they can deliver their RT editor to the CNS with a single AAV capsid

  • 4 hours ago
  • 1 min read

CEO Devyn Smith describes the significance of today's news. Arbor is thinking about numerous CNS conditions, including ALS. Plus, he shares an update on their liver mediated disease programs with partner Chiesi.




Coverage brought to you by



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page